CLAUDIA GRIMALDI - 17 Oct 2025 Form 4 Insider Report for IGC Pharma, Inc. (IGC)

Role
PFO, Director
Signature
/s/ Claudia Grimaldi
Issuer symbol
IGC
Transactions as of
17 Oct 2025
Transactions value $
$0
Form type
4
Filing time
21 Oct 2025, 08:44:11 UTC
Previous filing
15 May 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
GRIMALDI CLAUDIA PFO, Director 10224 FALLS ROAD, POTOMAC /s/ Claudia Grimaldi 21 Oct 2025 0001745853

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IGC Common Stock Gift $0 -50K -4.22% $0.00 1.13M 17 Oct 2025 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IGC Options Award $0 +1M $0.00 1M 17 Oct 2025 Common Stock 1M Direct F1
transaction IGC Options Award $0 +500K $0.00 500K 17 Oct 2025 Common Stock 500K Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted 1,000,000 options exercisable at $0.35, equally vesting over the next three years starting March 31st, 2026.
F2 The Reporting Person was granted Options subject to vesting according to specific milestones set by the Company's Board of Directors. The Options vest upon achievement of milestones. The exercise price is $0.35.
F3 Gift of shares of the Company's common stock to the reporting person's children who do not share the reporting person's household.